Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,953,679
-
Share change
-
-1,499,542
-
Total reported value
-
$5,196,209,674
-
Put/Call ratio
-
67%
-
Price per share
-
$173.48
-
Number of holders
-
209
-
Value change
-
-$232,814,603
-
Number of buys
-
128
-
Number of sells
-
70
Institutional Holders of LOXO ONCOLOGY INC - COM (LOXO) as of Q2 2018
As of 30 Jun 2018,
LOXO ONCOLOGY INC - COM (LOXO) was held by
209 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,953,679 shares.
The largest 10 holders included
Aisling Capital LLC, VANGUARD GROUP INC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, OppenheimerFunds, Inc., STATE STREET CORP, and FIL Ltd.
This page lists
209
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.